Lenka Boyd


Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on ‘preclinical and early-phase clinical pharmacology’

Leonetti, A., Boyd, L., Giuliani, J., Giovannetti, E., Garajová, I. & on Behalf of the EORTC PAMM Group, 2 Nov 2019, In : Expert Review of Clinical Pharmacology. 12, 11, p. 1033-1036 4 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells

Poel, D., Boyd, L. N. C., Beekhof, R., Schelfhorst, T., Pham, T. V., Piersma, S. R., Knol, J. C., Jimenez, C. R., Verheul, H. M. W. & Buffart, T. E., 19 Sep 2019, In : Cells. 8, 9

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

El Hassouni, B., Mantini, G., Li Petri, G., Capula, M., Boyd, L., Weinstein, H. N. W., Vallés-Marti, A., Kouwenhoven, M. C. M., Giovannetti, E., Westerman, B. A., Peters, G. J. & EORTC PAMM Group, 1 Jan 2019, In : Anticancer Research. 39, 7, p. 3303-3309 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review